Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Deglutition Disorders 2Tongue Neoplasms 1Speech Intelligibility 1Mouth Neoplasms 1Jaw Neoplasms 1Head and Neck Neoplasms 1Communication Disorders 1

Interventions

Cisplatin 416Radiotherapy 240Radiotherapy, Intensity-Modulated 178Cetuximab 177Docetaxel 166pembrolizumab 148Carboplatin 121Fluorouracil 113Paclitaxel 90Nivolumab 82Gemcitabine 82Radiation 72Surveys and Questionnaires 71Drug Therapy 70toripalimab 68Surgical Procedures, Operative 64Magnetic Resonance Spectroscopy 63Capecitabine 50Blood Specimen Collection 50Chemoradiotherapy 46Biopsy 44camrelizumab 41durvalumab 40Radiosurgery 40Standard of Care 38Erlotinib Hydrochloride 34nimotuzumab 32130-nm albumin-bound paclitaxel 32tislelizumab 31apatinib 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Deglutition × Head & Neck × Clear all
NCT05187091 2026-05-04

SWOAR

All India Institute of Medical Sciences

Phase 3 Recruiting
136 enrolled
Head & Neck

Deglutition Disorders, Head and Neck Neoplasms

NCT04126226 2019-10-15

Quality of Life in Patients Treated for Tongue and/or Jaw Neoplasia Before and After Speech Therapy

Hospital de Clinicas de Porto Alegre

Phase NA Completed
30 enrolled
Head & Neck

Communication Disorders, Deglutition Disorders, Jaw Neoplasms, Mouth Neoplasms, Speech Intelligibility, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡